focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Guys this looks undervalued so me so bought into both my SIPP and ISA yesterday at 808p
Was pleasantly surprised not to be charged any stamp duty on either transaction. Does anyone know why this wasn’t payable?
I've been quietly siting on this since buying in at c150p last year. For months it frustrated as it seemed to remain in the doldrums for ages.
The recovery has been slow coming, but, finally, it has gathered some pace now.
Still a further 25% upside to come before we hit the BC priice of 347p. I continue to HOLD until then.
Brokers. Always nice if they place A "Buy" recommendation on a stock you own, but, seriously, what a complete waste of space they are!
Thanks Baboy, good point about the profit taking so often happens after a sharp rise.
I remain committed to holding here, and nice to finally see some green again
Declared shorts of 1.72% are at their lowest level since 2017, so I don’t think they’re a significant factor any more?
Something is admittedly still dragging on the share price though. Apologies to anybody who listened to me when I called this a “buy” at 340p earlier in the month. It’s only gone backwards since then, not sure why :(
Matthew I’ve also been holding this since the 40s. Have top sliced along the way, but still holding over 50% of the original amount.
I’m inclined to let the rest ride from here myself.
The price before COVID was 173p. Management are talking about the excellent opportunities to come in the post-COVID world. I think they could easily top 200p again.
EK can't be that smart if he bought at 60p, thats the highest price seen at any point in the last 9 months.
Even if he wasn't alerted to PTRO until he saw the IC article on 19 April, he still had 2 days to get in under 50p!
Sorry, that should have said I CAN’T think of anything else trading at less than 50% of it pre-COVID price
Guys, it strikes me HYVE is one of the best COVID recovery-play stocks yet to see a big rebound.
I can think of anything else that’s still trading at less than 50% of it’s pre-COVID price. Any others you can name (and recommend)?
Out of interest, why do you think it can’t reach 300p?
I can see why the downward pressure - reasons highlighted by dreamachine - but ultimately this is a short term issue only IMO
We appear to be enetring big bargina territory again. Price pre-covid was touching £3; so potential upside of 150% for this recovery play.
As it is, price now is well below what it was in June 2020 when no-one had any idea when ia vacine would come, if they ever found one at all I wil be buying more if we approach 100p again.
Like all low cap mining firms, this is prime stock for a pump and dump
Sadly, thats exactly whats happened here. And, instead of avoiding these type of shares like i normally do, I'm one of the mugs who bought near the top :(
Not sure now what to do now. I hate seeing a share so deep into the red in my portfolio.
Thanks for the response Hexam.
I appreciate the company's prospects may have changed since COVID but as general rule of thumb, I'm making investment decisions across my portflio based upon comparing today's price vs 21 Feb 2020 price (that date being the last day before COVID hit markets).
It may be an overly- simplistic approach, but its also been an extremely profitable one up until now! Fingers crossed BAB will (now at last) follow the recovery in prices seen across the market elsewhere.
Ps I see the write off and clearing out of the balance sheet a massive positive in their favour since Feb 2020!
Just a reminder. Pre-COVID price was 500p, can't see any reason to sell (or go short) until we've bridged the gap to that price.
STROMG BUY recommendation - as indicated this morning - stands
It's only a curious reaction if you think the potential write down hadn't been factored in during the price drop from 1000p a few years ago to 240p now.
Bag of fag packet calulation tells me approx £5 billion has been wiped off the market cap since 2016 and the £1.7 bn write down is is only a third of that.
Guys as I mentioned the other day, a bounce was to be expected when the bs review was completed. Now it’s completed, and we have no equity raise confirmed, the bounce can be followed by a steady rise upwards..
Do t forget, BAB was trading at 360p a few months ago, 500p pre COVID and 1000p 5 years ago.
Realistic first target from here is the 500p pre-COVID price . STRONG BUY.
Couldn’t agree more
Every time I review my portfolio and ask the question: should I cash in my profit on UAI ? The answer is a resounding NO. Share price pre-Covid was 186p which means we’re only half-way on the recovery.
I wish they’d just get on and do this bloody write down. Confident we’ll see a bounce once it happens. In the meantime, we just continue taking a hammering.